Simon Lord‐Dufour

CHO cell production of a single, enveloped VLP vaccine co-displaying SARS-CoV-2, influenza and RSV antigens

Abstract Concurrent circulation of SARS-CoV-2, influenza A (IAV), and respiratory syncytial virus (RSV) remains a major public health concern, driving the need for multivalent, combined vaccines. Here, we report the generation of trivalent enveloped virus-like particles (eVLPs) c...